chr10-92848551-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000260762.10(EXOC6):āc.18G>Cā(p.Glu6Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000737 in 1,424,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000260762.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXOC6 | NM_019053.6 | c.18G>C | p.Glu6Asp | missense_variant | 1/22 | ENST00000260762.10 | NP_061926.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXOC6 | ENST00000260762.10 | c.18G>C | p.Glu6Asp | missense_variant | 1/22 | 1 | NM_019053.6 | ENSP00000260762.6 |
Frequencies
GnomAD3 genomes AF: 0.0000466 AC: 7AN: 150350Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000453 AC: 8AN: 176604Hom.: 0 AF XY: 0.0000613 AC XY: 6AN XY: 97952
GnomAD4 exome AF: 0.0000769 AC: 98AN: 1274370Hom.: 0 Cov.: 33 AF XY: 0.0000774 AC XY: 49AN XY: 633324
GnomAD4 genome AF: 0.0000466 AC: 7AN: 150350Hom.: 0 Cov.: 32 AF XY: 0.0000409 AC XY: 3AN XY: 73374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2023 | The c.18G>C (p.E6D) alteration is located in exon 1 (coding exon 1) of the EXOC6 gene. This alteration results from a G to C substitution at nucleotide position 18, causing the glutamic acid (E) at amino acid position 6 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at